Midnight MarketsV1.0
⚠ Not financial adviceNot financial advice. Independent research, not investment recommendations. The author and website make no representation as to accuracy or completeness. Do your own due diligence before acting on anything you read here. Read the full disclaimer →
The Peptide CDMOs — Making the GLP-1 Molecules · The GLP-1 & Bio Supply Chain — Peptides, Bioprocessing & Diagnostics

PPGN.SW

PolyPeptide Group
Foreign listing — not directly tradable in a US brokerage. Editorial detail only.

#2 global peptide CDMO. €100M Malmö SPPS expansion underway.

What they do

Swiss #2 peptide CDMO behind Bachem. Smaller, more turnaround-focused. €100M Malmö SPPS expansion underway. Higher beta way to play the same GLP-1 thesis with more upside if execution holds — but also more downside if customers concentrate orders at Bachem.